| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CYTOKINETICS INC | EVP, Chief Financial Officer | Common Stock | 34.7K | $1.7M | $48.88 | May 31, 2024 | Direct |
| Vir Biotechnology, Inc. | EVP & Chief Financial Officer | Common Stock | 100K | $994K | $9.89 | Mar 27, 2024 | Direct |
| Vir Biotechnology, Inc. | EVP & Chief Financial Officer | Stock Option (Right to Buy) | 80K | $122K | $1.53 | Feb 22, 2024 | Direct |
| CYTOKINETICS INC | EVP, Chief Financial Officer | Non-Qualified Stock Option (Right to Buy) | 53.4K | May 31, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | May 31, 2024 | 2 | $0 | 4 | Jun 3, 2024 | EVP, Chief Financial Officer |
| CYTK | CYTOKINETICS INC | Apr 26, 2024 | 0 | $0 | 3 | Apr 30, 2024 | EVP, Chief Financial Officer |
| VIR | Vir Biotechnology, Inc. | Mar 27, 2024 | 1 | -$59.4K | 4 | Mar 28, 2024 | EVP & Chief Financial Officer |
| VIR | Vir Biotechnology, Inc. | Feb 22, 2024 | 2 | $0 | 4 | Feb 26, 2024 | EVP & Chief Financial Officer |
| VIR | Vir Biotechnology, Inc. | Mar 27, 2023 | 2 | $0 | 4 | Mar 29, 2023 | Chief Financial Officer |
| VIR | Vir Biotechnology, Inc. | Mar 27, 2023 | 0 | $0 | 3 | Mar 29, 2023 | Chief Financial Officer |